2451 - 2500 of 8100 Results
Title
Year
- OPENTitle: Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00260-0Best OA location URL: https://www.nature.com/articles/s41531-021-00260-0.pdfCitation Count: 21
- RESTRICTEDTitle: Relationship of Genotype, Phenotype, and Treatment in Dopa‐Responsive Dystonia: MDSGene ReviewJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 237End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28874Best OA location URL: https://discovery.ucl.ac.uk/10141742/1/Kurian_Relationship%20of%20Genotype%2C%20Phenotype%2C%20and%20Treatment%20in%20Dopa-Responsive%20Dystonia_AOP.pdfCitation Count: 23
- RESTRICTEDTitle: Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?Journal Name: Nature Reviews NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 2Start Page: 115End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41583-021-00542-9Citation Count: 90
- OPENTitle: Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasisJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.15252/embj.2020105531Best OA location URL: https://doi.org/10.15252/embj.2020105531Citation Count: 17
- OPENTitle: Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database AnalysisJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 435End Page: 448Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00309-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00309-5.pdfCitation Count: 9
- OPENTitle: Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over timeJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 6Issue #:Start Page: 100126End Page: 100126Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100126Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100126Citation Count: 1
- Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns2021OPENTitle: Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patternsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 5Start Page: 1743End Page: 1756Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab440Best OA location URL: https://academic.oup.com/brain/article-pdf/145/5/1743/43948322/awab440.pdfCitation Count: 40
- OPENTitle: Heterozygous PRKN mutations are common but do not increase the risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 6Start Page: 2077End Page: 2091Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1093/brain/awab456Best OA location URL: https://academic.oup.com/brain/article-pdf/145/6/2077/45614432/awab456.pdfCitation Count: 48
- OPENTitle: Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson’s Disease Motor ProgressionJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.765765Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.765765/pdfCitation Count: 7
- OPENTitle: Self‐Report versus Clinician Examination in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 585End Page: 597Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28884Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299700Citation Count: 16
- RESTRICTEDTitle: Leucine rich repeat kinase 2 (LRRK2) peptide modulators: Recent advances and future directionsJournal Name: Peptide SciencePublisher: WileyVol: 114Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/pep2.24251Citation Count: 0
- OPENTitle: 3D convolutional neural networks for classification of Alzheimer’s and Parkinson’s disease with T1-weighted brain MRIJournal Name: 17th International Symposium on Medical Information Processing and AnalysisPublisher: SPIEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/12.2606297Best OA location URL: https://doi.org/10.1101/2021.07.26.453903Citation Count: 1
- OPENTitle: Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson diseaseJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 137Issue #: 1Start Page: 184End Page: 191Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3171/2021.7.jns21190Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117559Citation Count: 7
- OPENTitle: Deep learning-based brain transcriptomic signatures associated with the neuropathological and clinical severity of Alzheimer’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab293Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/1/fcab293/42475382/fcab293.pdfCitation Count: 16
- OPENTitle: Llamanade: An open-source computational pipeline for robust nanobody humanizationJournal Name: StructurePublisher: Elsevier BVVol: 30Issue #: 3Start Page: 418End Page: 429.e3Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.str.2021.11.006Best OA location URL: https://doi.org/10.1016/j.str.2021.11.006Citation Count: 32
- OPENTitle: Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based studyJournal Name: The Lancet Regional Health - AmericasPublisher: Elsevier BVVol: 7Issue #:Start Page: 100136End Page: 100136Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.lana.2021.100136Best OA location URL: https://doi.org/10.1016/j.lana.2021.100136Citation Count: 25
- OPENTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 26
- OPENTitle: Systematic analysis of PINK1 variants of unknown significance shows intact mitophagy function for most variantsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00258-8Best OA location URL: https://www.nature.com/articles/s41531-021-00258-8.pdfCitation Count: 9
- A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in Tissue2021OPENTitle: A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in TissueJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 125Issue #: 50Start Page: 13710End Page: 13717Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jpcb.1c07762Best OA location URL: https://www.pure.ed.ac.uk/ws/files/248515310/Gorka_PAP1AmyloidFLIM_MS_Accepted.pdfCitation Count: 4
- OPENTitle: Self-normalized Classification of Parkinson’s Disease DaTscan ImagesJournal Name: 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/bibm52615.2021.9669820Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006242Citation Count: 2
- RESTRICTEDTitle: The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 4Start Page: 1000End Page: 1010Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.15201Citation Count: 4
- OPENTitle: Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s DiseaseJournal Name: DiagnosticsPublisher: MDPI AGVol: 11Issue #: 12Start Page: 2303End Page: 2303Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/diagnostics11122303Best OA location URL: https://www.mdpi.com/2075-4418/11/12/2303/pdf?version=1638953319Citation Count: 11
- OPENTitle: PhosPiR: an automated phosphoproteomic pipeline in RJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/bib/bbab510Best OA location URL: https://academic.oup.com/bib/article-pdf/23/1/bbab510/43308900/bbab510.pdfCitation Count: 8
- OPENTitle: Protein Profiling of RGS6, a Pleiotropic Gene Implicated in Numerous Neuropsychiatric Disorders, Reveals Multi-Isoformic Expression and a Novel Brain-Specific IsoformJournal Name: eneuroPublisher: Society for NeuroscienceVol: 9Issue #: 1Start Page: ENEURO.0379End Page: 21.2021Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0379-21.2021Best OA location URL: https://www.eneuro.org/content/eneuro/9/1/ENEURO.0379-21.2021.full.pdfCitation Count: 9
- Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies2021OPENTitle: Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathiesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 2Start Page: 584End Page: 595Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab431Best OA location URL: https://academic.oup.com/brain/article-pdf/145/2/584/43402317/awab431.pdfCitation Count: 92
- OPENTitle: Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasoundJournal Name: OncotargetPublisher: Impact Journals, LLCVol: 12Issue #: 25Start Page: 2437End Page: 2448Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.18632/oncotarget.28139Best OA location URL: https://www.oncotarget.com/article/28139/pdf/Citation Count: 16
- OPENTitle: Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 689End Page: 697Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212959Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212959?id=journal-of-parkinsons-disease%2Fjpd212959Citation Count: 6
- Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex2021OPENTitle: Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complexJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 1Start Page: 44End Page: 59.e6Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.012Best OA location URL: http://www.cell.com/article/S1097276521009916/pdfCitation Count: 68
- OPENTitle: Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivoJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 50Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.2108489118Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685670Citation Count: 28
- OPENTitle: [18F]Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s DiseaseJournal Name: MoleculesPublisher: MDPI AGVol: 26Issue #: 23Start Page: 7360End Page: 7360Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules26237360Best OA location URL: https://www.mdpi.com/1420-3049/26/23/7360/pdf?version=1638601226Citation Count: 14
- RESTRICTEDTitle: GPi‐DBS for KMT2B‐Associated Dystonia: Systematic Review and Meta‐AnalysisJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 1Start Page: 31End Page: 37Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13374Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13374Citation Count: 15
- OPENTitle: How Parkinson’s patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide surveyJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 95Issue #:Start Page: 20End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2021.11.017Citation Count: 7
- RESTRICTEDTitle: The Human Tic Detector: An automatic approach to tic characterization using wearable sensorsJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 134Issue #:Start Page: 102End Page: 110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2021.10.017Citation Count: 9
- OPENTitle: White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementiaJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 111Issue #:Start Page: 54End Page: 63Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.11.007Best OA location URL: http://escholarship.mcgill.ca/downloads/ns064b900Citation Count: 43
- OPENTitle: Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-27204-9Best OA location URL: https://www.nature.com/articles/s41467-021-27204-9.pdfCitation Count: 32
- OPENTitle: Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 10Start Page: 1754End Page: 1764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12505Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160203Citation Count: 7
- RESTRICTEDTitle: For Some Neurologists, COVID-19 Has Prompted an ‘Existential Crisis’Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 1,22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805196.94665.beCitation Count: 0
- RESTRICTEDTitle: How to Increase Diverse Representation in Parkinson's Disease TrialsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 20End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805216.68841.48Citation Count: 0
- OPENTitle: Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on NeuroinflammationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 59Issue #: 2Start Page: 1140End Page: 1150Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02625-1Citation Count: 12
- RESTRICTEDTitle: MS Study That Spans Decades Indicates Patients Benefit from Early Diagnosis and TreatmentJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 1,17End Page: 20Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805208.98399.94Citation Count: 0
- RESTRICTEDTitle: Multiplexed Profiling of Extracellular Vesicles for Biomarker DevelopmentJournal Name: Nano-Micro LettersPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40820-021-00753-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40820-021-00753-w.pdfCitation Count: 42
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 65
- OPENTitle: The contribution of behavioral features to caregiver burden in FTLD spectrum disordersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 9Start Page: 1635End Page: 1649Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12494Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160199Citation Count: 14
- RESTRICTEDTitle: A brief history of nearly EV‐erything – The rise and rise of extracellular vesiclesJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 14Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/jev2.12144Best OA location URL: http://pure-oai.bham.ac.uk/ws/files/158007662/J_of_Extracellular_Vesicle_2021_Couch_A_brief_history_of_nearly_EV_erything_The_rise_and_rise_of_extracellular.pdfCitation Count: 176
- OPENTitle: A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid BindingJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 433Issue #: 24Start Page: 167323End Page: 167323Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2021.167323Best OA location URL: https://purehost.bath.ac.uk/ws/files/226493626/SI_Resubmission.pdfCitation Count: 8
- RESTRICTEDTitle: Amantadine in the treatment of Parkinson's disease and other movement disordersJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1048End Page: 1056Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00249-0Citation Count: 73
- RESTRICTEDTitle: Autophagy and the hallmarks of agingJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 72Issue #:Start Page: 101468End Page: 101468Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.arr.2021.101468Best OA location URL: http://manuscript.elsevier.com/S1568163721002154/pdf/S1568163721002154.pdfCitation Count: 115
- RESTRICTEDTitle: Corrigendum to “Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys” [EBioMedicine 2020; 59:102944]Journal Name: eBioMedicinePublisher: Elsevier BVVol: 74Issue #:Start Page: 103731End Page: 103731Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2021.103731Best OA location URL: http://www.thelancet.com/article/S2352396421005259/pdfCitation Count: 0
- OPENTitle: Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratoriesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00491-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00491-yCitation Count: 42
- RESTRICTEDTitle: Disease modifying therapies for Parkinson's disease: Novel targetsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 201Issue #:Start Page: 108839End Page: 108839Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108839Citation Count: 4